Recombinant Escherichia coli O17:K52:H18 Nicotinate phosphoribosyltransferase (pncB)

Shipped with Ice Packs
In Stock

Description

Enzyme Function and Biological Role

Nicotinate phosphoribosyltransferase (NAPRTase), encoded by the pncB gene, catalyzes the conversion of nicotinic acid (NA) to nicotinic acid mononucleotide (NAMN), a precursor in NAD biosynthesis. NAD is essential for redox reactions, energy metabolism, and DNA repair . In E. coli, pncB overexpression increases intracellular NAD levels by up to 5-fold, enhancing metabolic flux in pathways dependent on this cofactor .

Recombinant Expression Systems

Recombinant pncB is typically produced in heterologous hosts like E. coli or yeast. Key features include:

ParameterDetails
Host SystemE. coli BL21(DE3) or yeast
TagN-terminal His-tag for purification
Purity>85–90% (confirmed via SDS-PAGE)
StorageLyophilized in Tris/PBS buffer with trehalose or glycerol
Activity25-fold increase in enzyme activity observed with multicopy plasmids

For example, recombinant pncB in E. coli BL21(DE3) under a T7 promoter achieved extracellular nicotinamide mononucleotide (NMN) titers of 1.11 g·L⁻¹ when combined with ATP cycle optimization .

Applications in Metabolic Engineering

Recombinant pncB is pivotal in NAD-dependent bioproduction:

  • NAD Pool Enhancement: Overexpression elevates NAD concentrations, improving yields in succinic acid (1.11 g·L⁻¹) and NMN (1.01 g·L⁻¹) production .

  • Cofactor Balancing: Coupling pncB with transporters like PnuC from Bacillus mycoides enhances extracellular NMN secretion .

Regulatory and Kinetic Insights

  • Repression by Nicotinic Acid: Native pncB expression is strongly repressed by NA, necessitating inducible promoters (e.g., T7 or Trc) for recombinant systems .

  • Catalytic Efficiency: Vₘₐₓ and Kₘ values for NA remain uncharacterized in O17:K52:H18 but align with general E. coli kinetics in other strains .

Research Gaps and Future Directions

  • O17:K52:H18-Specific Studies: No direct data exist on pncB regulation or structure in this strain.

  • Industrial Scaling: Optimizing fermentation conditions (e.g., NA feeding, glucose concentration) could improve NMN yields .

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. All proteins are shipped with normal blue ice packs by default. Request dry ice in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
pncB; ECUMN_1125; Nicotinate phosphoribosyltransferase; NAPRTase; EC 6.3.4.21
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-400
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli O17:K52:H18 (strain UMN026 / ExPEC)
Target Names
pncB
Target Protein Sequence
MTQFASPVLH SLLDTDAYKL HMQQAVFHHY YDVHVAAEFR CRGDDLLGIY ADAIREQVQA MQHLRLQDDE YQWLSALPFF KADYLNWLRE FRFNPEQVTV SNDNGKLDIR LSGPWREVIL WEVPLLAVIS EMVHRYRSPQ ADVAQALDTL ESKLADFSAL TAGLDMSRFH LMDFGTRRRF SREVQETIVK RLQQESWFVG TSNYDLARRL SLTPMGTQAH EWFQAHQQIS PDLANSQRAA LAAWLEEYPD QLGIALTDCI TMDAFLRDFG VEFASRYQGL RHDSGDPVEW GEKAIAHYEK LGIDPQSKTL VFSDNLDLRK AVELYRHFSS RVQLSFGIGT RLTCDIPQVK PLNIVIKLVE CNGKPVAKLS DSPGKTICHD KAFVRALRKA FDLPHIKKAS
Uniprot No.

Target Background

Function
Catalyzes the synthesis of beta-nicotinate D-ribonucleotide from nicotinate and 5-phospho-D-ribose 1-phosphate using ATP.
Database Links
Protein Families
NAPRTase family

Q&A

What is the function of nicotinate phosphoribosyltransferase (NAPRTase) in E. coli metabolism?

Nicotinate phosphoribosyltransferase (NAPRTase), encoded by the pncB gene, catalyzes the formation of nicotinate mononucleotide (NAMN) from nicotinic acid (NA) and phosphoribosyl pyrophosphate. This reaction represents a critical and rate-limiting step in the NAD salvage pathway in Escherichia coli. The enzyme plays a fundamental role in recycling intracellular NAD breakdown products and utilizing preformed pyridine compounds from the environment. NAMN serves as a direct precursor for NAD synthesis, making NAPRTase essential for maintaining proper redox balance within bacterial cells .

How does the NAD salvage pathway differ from the de novo NAD synthesis pathway in E. coli?

E. coli maintains its total NADH/NAD+ intracellular pool through two distinct pathways:

  • De novo NAD synthesis pathway: Synthesizes NAD from scratch using basic cellular precursors

  • Pyridine nucleotide salvage pathway: Recycles intracellular NAD breakdown products and utilizes preformed pyridine compounds from the environment

The salvage pathway is more energy-efficient as it reuses existing NAD components rather than synthesizing them from basic precursors. The rate-limiting step in the salvage pathway is catalyzed by NAPRTase (encoded by pncB), which forms NAMN from nicotinic acid. This pathway becomes particularly important under energy-limited conditions where efficiency of NAD synthesis is crucial .

What experimental models are commonly used to study pncB function in E. coli?

Researchers typically employ several experimental models to study pncB function:

  • Chemostat cultures: Continuous culture systems allowing maintenance of steady-state conditions with fixed metabolic rates

  • Anaerobic tube experiments: Batch cultivation under oxygen-limited conditions to examine transient metabolic responses

  • Genetic overexpression systems: Plasmid-based expression of pncB genes (often from related organisms like Salmonella typhimurium) in E. coli to assess phenotypic effects

  • Combined genetic manipulations: Simultaneous manipulation of pncB with other NAD-related genes, such as replacing native cofactor-independent formate dehydrogenase with an NAD+-dependent version

These models allow researchers to investigate metabolic flux distributions and NAD/NADH ratios under various growth conditions and genetic backgrounds .

How does pncB overexpression affect NAD homeostasis and metabolic flux distribution in E. coli under different growth conditions?

The effects of pncB overexpression on NAD homeostasis and metabolic flux distribution vary significantly depending on growth conditions:

Under chemostat conditions (steady-state):

  • Increased total NAD levels

  • Decreased NADH/NAD+ ratio

  • No significant redistribution of metabolic fluxes

Under anaerobic tube conditions (transient/batch):

  • Significant shift in metabolic patterns

  • Decreased lactate production

  • Increased ethanol-to-acetate (Et/Ac) ratio by up to two-fold

What molecular techniques can optimize expression of recombinant pncB in E. coli expression systems?

Several molecular techniques can be employed to optimize expression of recombinant pncB:

  • N-terminal sequence optimization: The nucleotides immediately following the start codon significantly influence protein expression. Using directed evolution-based methodology with DNA libraries coding for diverse N-termini can increase protein yield up to 30-fold .

  • Fluorescence-activated cell sorting (FACS) screening: Tagging pncB with GFP at the C-terminus allows for high-throughput screening of expression levels. This approach enables identification of cells with increased expression from large libraries .

  • Codon optimization: Adjusting codon usage to match E. coli preferences can enhance translation efficiency.

  • Signal sequence modifications: Proper design of signal sequences can ensure appropriate subcellular localization and prevent protein degradation.

  • Expression vector selection: Choosing appropriate promoters, ribosome binding sites, and vector copy numbers can significantly affect expression levels.

  • Growth condition optimization: Temperature, induction timing, and media composition can be adjusted to maximize protein production while maintaining solubility .

What is the relationship between pncB overexpression and metabolic engineering strategies for biofuel production in E. coli?

The relationship between pncB overexpression and biofuel production in E. coli is particularly relevant for ethanol production pathways:

Overexpression of pncB has been shown to increase the ethanol-to-acetate ratio by up to two-fold under anaerobic conditions. This occurs because:

  • Increased NAD availability enhances the activity of NADH-dependent alcohol dehydrogenase

  • The altered NADH/NAD+ ratio shifts metabolic flux toward NADH-consuming pathways

  • Reduced lactate production indicates redistribution of metabolic flux toward ethanol synthesis

This metabolic shift is particularly significant for biofuel production strategies, as ethanol is a desired product while acetate is often considered a wasteful byproduct. Furthermore, combining pncB overexpression with other metabolic engineering strategies, such as introducing NAD+-dependent formate dehydrogenase, presents opportunities for synergistic enhancement of biofuel yields .

How can directed evolution strategies improve pncB expression and activity in recombinant systems?

Directed evolution offers a powerful approach to optimize pncB expression and activity:

  • Creation of diverse genetic libraries: Generate libraries with randomized N-terminal sequences of pncB using degenerate primers and PCR techniques.

  • High-throughput screening: Employ GFP fusion strategies to enable fluorescence-based screening of expression levels using FACS, allowing evaluation of tens of thousands of variants per second.

  • Selection rounds: Perform multiple rounds of sorting, with each round selecting cells with highest fluorescence intensity, indicating improved expression.

  • Verification of improved variants: Confirm enhanced expression through protein quantification methods such as SDS-PAGE and Western blotting.

  • Activity assays: Validate that improved expression correlates with enhanced NAPRTase activity using enzymatic assays.

This systematic workflow can elevate soluble recombinant protein yields by up to 30-fold compared to unoptimized constructs. Unlike approaches relying on a few rationally designed sequences, directed evolution enables exploration of a much broader sequence space, increasing the likelihood of identifying optimal variants .

What analytical methods are most effective for measuring NAD/NADH ratios and metabolic flux changes in pncB-modified E. coli strains?

Effective analytical methods for measuring NAD/NADH ratios and metabolic flux in pncB-modified strains include:

For NAD/NADH quantification:

  • Enzymatic cycling assays that specifically measure NAD+ and NADH levels

  • HPLC-based methods for direct quantification of pyridine nucleotides

  • Bioluminescence assays using NAD/NADH-dependent luciferase systems

  • Fluorescence-based assays utilizing NAD/NADH-dependent dehydrogenases

For metabolic flux analysis:

  • Quantification of extracellular metabolites (ethanol, acetate, lactate, etc.) using HPLC or GC-MS

  • 13C-metabolic flux analysis using isotope-labeled glucose and mass spectrometry

  • Respirometry to measure oxygen consumption and CO2 production rates

  • Real-time monitoring of key metabolites using biosensors

For whole-system analysis:

  • Transcriptomics to identify gene expression changes in related metabolic pathways

  • Proteomics to quantify changes in enzyme levels

  • Metabolomics to provide comprehensive metabolite profiles

Integration of these multiple analytical approaches provides a comprehensive understanding of how pncB modifications affect cellular metabolism and NAD homeostasis .

How does pncB overexpression impact key metabolic parameters in E. coli under different growth conditions?

The impact of pncB overexpression varies significantly between growth conditions as shown in the following data table:

ParameterChemostat Conditions (Steady-State)Anaerobic Tube Conditions (Transient)
Total NAD levelsIncreasedIncreased
NADH/NAD+ ratioDecreasedVariable
Metabolic flux redistributionNo significant changeSignificant redistribution
Lactate productionMinimal changeDecreased
Ethanol-to-acetate ratioMinimal changeIncreased up to 2-fold
Growth rateFixed by dilution ratePotentially affected

What are the comparative advantages and limitations of different expression systems for recombinant pncB production?

Various expression systems offer distinct advantages and limitations for recombinant pncB production:

Expression SystemAdvantagesLimitationsYield Enhancement Potential
pET vectors (T7 promoter)High expression levels; Tight regulationPotential inclusion body formation; Metabolic burdenUp to 25-fold with optimized conditions
pBAD vectors (arabinose induction)Tunable expression; Reduced toxicityLower maximum expression; Catabolite repression issuesUp to 15-fold with fine-tuned induction
pTrc/pTac systemsGood balance of expression and solubility; Well-characterizedLeaky expression; Moderate yieldsUp to 10-fold with optimized conditions
N-terminal fusion tags (His, GST, MBP)Enhanced solubility; Simplified purificationTag removal complications; Potential activity interference5-20-fold depending on fusion partner
N-terminal sequence optimizationImproved translation initiation; Enhanced solubilityRequires extensive screening; Protein-specificUp to 30-fold using directed evolution approach

The optimization of N-terminal sequences through directed evolution methods offers particularly promising results, with documented yield increases of up to 30-fold for various recombinant proteins. This approach focuses on enhancing the translation initiation efficiency and protein folding, which are often bottlenecks in recombinant protein production .

What molecular mechanisms explain the different metabolic outcomes between steady-state and transient conditions in pncB-overexpressing E. coli?

The contrasting metabolic responses observed between steady-state (chemostat) and transient (batch) conditions in pncB-overexpressing E. coli can be explained by several molecular mechanisms:

  • Metabolic Control Architecture:

    • In steady-state conditions, flux control is distributed across multiple enzymes

    • Altering single enzyme abundances (like NAPRTase) has limited impact due to system homeostasis

    • Flux control coefficients for NAD-utilizing enzymes appear to be low under these conditions

  • NAD Pool Dynamics:

    • Under transient conditions, rapid growth and changing environments create dynamic NAD demands

    • Increased NAD availability becomes growth-limiting during metabolic transitions

    • The NADH/NAD+ ratio fluctuates more dramatically during batch growth

  • Enzyme Saturation Effects:

    • NADH-dependent alcohol dehydrogenase operates below saturation in transient conditions

    • Increased NAD pool enhances activity proportionally

    • In steady-state, many enzymes operate near saturation, diminishing the impact of increased cofactor availability

  • Regulatory Responses:

    • Transcriptional regulation adapts to altered NADH/NAD+ ratios over time in batch culture

    • Steady-state cultures have already adapted regulatory networks to the modified redox state

    • Key transcription factors (FNR, ArcA) respond differently under the two conditions

These mechanisms collectively explain why pncB overexpression significantly alters metabolic flux distribution under transient conditions while having minimal effect under steady-state conditions, despite increasing total NAD levels in both scenarios .

What emerging technologies could enhance our understanding of pncB function and NAD metabolism in E. coli?

Several emerging technologies show promise for advancing our understanding of pncB function and NAD metabolism:

  • CRISPR-based tools: CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) systems allow for precise tuning of pncB expression levels without permanent genetic modifications.

  • Real-time NAD/NADH biosensors: Genetically encoded fluorescent biosensors can provide spatiotemporal information about NAD/NADH ratios within living cells.

  • Single-cell metabolomics: New mass spectrometry approaches enable metabolite profiling at the single-cell level, revealing population heterogeneity in NAD metabolism.

  • Microfluidic cultivation systems: These systems allow precise control of environmental conditions while enabling real-time monitoring of cellular responses.

  • Multi-omics integration: Combining transcriptomics, proteomics, and metabolomics data with machine learning approaches can reveal complex regulatory networks controlling NAD homeostasis.

  • Cell-free systems: Reconstituted cell-free metabolism allows precise control over component concentrations and simplifies the study of NAD-related pathways.

These technologies will enable researchers to address key questions regarding the dynamic regulation of NAD metabolism and its relationship to broader cellular functions in E. coli .

How might findings from pncB research in E. coli translate to applications in synthetic biology and metabolic engineering?

Research findings on pncB in E. coli have several promising applications in synthetic biology and metabolic engineering:

  • Biofuel production optimization: The demonstrated ability of pncB overexpression to increase ethanol-to-acetate ratios could be exploited to enhance biofuel yields.

  • Redox balance engineering: Manipulating NAD pools through pncB could enable fine-tuning of cellular redox states for production of reduced compounds.

  • Protein production platforms: The directed evolution approaches used for optimizing recombinant protein expression could be applied to industrial enzyme production.

  • Synthetic NAD-dependent pathways: Enhanced understanding of NAD metabolism could facilitate the design of artificial metabolic pathways requiring NAD cofactors.

  • Strain robustness improvement: Optimized NAD metabolism could enhance strain tolerance to industrial conditions and metabolic stresses.

  • Dynamic regulatory circuits: Incorporating NAD-sensing elements into synthetic circuits could enable responsive control of metabolic pathways.

  • Multi-enzyme cascade optimization: Balancing NAD regeneration with NAD-dependent enzymatic steps could improve efficiency of in vitro and in vivo biocatalytic cascades.

The translation of fundamental knowledge about pncB function into practical applications represents an exciting frontier in metabolic engineering and synthetic biology research .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.